Last Updated: May 15, 2024
moleculardiseaseburden.com has 4 NS records, 8 A records, 0 AAAA records, 0 MX records, and 0 TXT records. Name servers for moleculardiseaseburden.com are ns-732.awsdns-27.net, ns-1767.awsdns-28.co.uk, ns-446.awsdns-55.com, ns-1144.awsdns-15.org. A records for moleculardiseaseburden.com are 52.218.180.138, 52.92.196.67, 52.92.133.163, 52.92.224.91, 52.92.248.139, 52.92.192.123, 52.218.235.10, 52.92.176.251. We have observed moleculardiseaseburden.com to have 1 subdomains. A subdomain count of 1 is considered a small digital footprint. The domain's primary website is hosted on a AmazonS3 web server at 52.218.217.138 in United States. The website's description is: "signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it."
Search DigitalStakeout Footprint to find another asset.
52.218.180.138
52.92.196.67
52.92.133.163
52.92.224.91
52.92.248.139
52.92.192.123
52.218.235.10
52.92.176.251
No DNS AAAA records
No DNS MX records
ns-732.awsdns-27.net
ns-1767.awsdns-28.co.uk
ns-446.awsdns-55.com
ns-1144.awsdns-15.org
No DNS TXT records
moleculardiseaseburden.com has 1 subdomains in our inventory.
AmazonS3
52.218.217.138
United States
og:locale: en_us
og:type: article
og:title: signatera overview
og:description: signatera™ is a sensitive ctdna test for colorectal cancer that can identify relapse sooner than standard tools. click here to learn more about it.
og:url: https://www.natera.com/oncology/signatera-advanced-cancer-detection/
og:site_name: natera
article:publisher: https://www.facebook.com/nateragenetics
article:modified_time: 2024-04-25t23:12:21+00:00
og:image: https://www.natera.com/wp-content/uploads/2022/08/icon-medicare.png
No certificate log entry found for moleculardiseaseburden.com. Please check back at a later time.